Immunogenicity and safety of COVID-19 vaccine in lung cancer patients receiving anticancer treatment: A prospective multicenter cohort study

• Main Authors: Kei Nakashima (Author), Masayuki Ishida (Author), Hiroki Matsui (Author), Chihiro Yoshida (Author), Tatsuya Nagai (Author), Minoru Shiraga (Author), Hiroshi Nakaoka (Author), Yoshihito Otsuka (Author), Yu Nakagama (Author), Natsuko Kaku (Author), Yuko Nitahara (Author), Yasutoshi Kido (Author), Yoshio Hirota (Author)
• Format: Book
• Published: Taylor & Francis Group, 2022-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

This study assessed the immunogenicity and safety of the BNT162b2 mRNA vaccine in lung cancer patients receiving anticancer treatment. We enrolled lung cancer patients receiving anticancer treatment and non-cancer patients; all participants were fully vaccinated with the BNT162b2 vaccine. Blood samp...